Human Pathology
Volume 36, Issue 5 , Pages 536-545, May 2005

The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries

  • Victor E. Gould, MD

      Affiliations

    • Department of Pathology, Rush Medical College, Chicago, Ill 60611, USA
    • Corresponding Author InformationCorresponding author.
  • ,
  • Juan Miguel Mosquera, MD

      Affiliations

    • Department of Pathology, Rush Medical College, Chicago, Ill 60611, USA
  • ,
  • Kerstin Leykauf, BSc

      Affiliations

    • German Cancer Research Center, D-62109 Heidelberg, Germany
  • ,
  • Paolo Gattuso, MD

      Affiliations

    • Department of Pathology, Rush Medical College, Chicago, Ill 60611, USA
  • ,
  • Matthias Dürst, PhD

      Affiliations

    • Women's Clinic, University of Jena, D-07740 Jena, Germany
  • ,
  • Angel Alonso, PhD

      Affiliations

    • German Cancer Research Center, D-62109 Heidelberg, Germany

Summary 

We applied an antiserum (SA226P) specifically recognizing the phosphorylated form of connexin43 (P-Cx43) to human breast samples including normal breast samples, with fibrocystic disease (FCD), fibroadenomas (FA), in situ and infiltrating carcinomas of all major types, and miscellaneous extramammary tumors. The findings were compared with those obtained with commercial antisera recognizing all Cx43 forms (pan-Cx43). A subset of samples was stained for Her2-neu and p44/42 to mitogen-activated protein kinase. Paraffin step sections were used. Immunoblots were performed on frozen samples of a representative subset of cases. In the normal breast, FCD, and FA, SA226P stained strongly and extensively most myoepithelial cells (MECs); luminal cells remained unstained. In proliferative FCD and some cellular FA, SA226P stained MEC and the capillary endothelium (CE). In ductal and lobular in situ carcinomas, SA226P reacted strongly and diffusely with the remaining MEC, the CE, and the transformed luminal cells. SA226P stained all infiltrating carcinomas except the tubular variant. In all breast carcinomas, the CE within and adjacent to tumors and some myofibroblasts stained with SA226P. By contrast, pan-Cx43 stained weakly and sporadically the MEC and rare samples of invasive carcinomas. Notably, Mab p44/42 reacted in parallel with the samples stained with SA226P, whereas reactions with Her2 were negative. Immunoblot findings paralleled those obtained immunohistochemically. We conclude that P-Cx43, restricted to MEC in the normal breast, is up-regulated in the same cells in hyperplasias and dysplasias and FA and is strongly up-regulated in invasive carcinomas. Notably, in some proliferative FCD and in most in situ and infiltrating carcinomas, P-Cx43 is strongly expressed in CE within and adjacent to the lesions but not away from them. These findings were paralleled by the strong nuclear reactions noted with Mab p44/42. These phenomena, although not exclusive to malignancy, are particularly conspicuous in breast carcinomas and seemingly reflect active proliferation associated with abnormal gap junctional intercellular communication.

Keywords: Gap junctions, Connexin43, Phosphorylation, Breast, Carcinomas, Immunohistochemistry

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0046-8177(05)00164-4

doi:10.1016/j.humpath.2005.03.013

Human Pathology
Volume 36, Issue 5 , Pages 536-545, May 2005